Therapeutic potential of implanted tissue-engineered bioartificial muscles delivering recombinant proteins to the sheep heart.
Tissue-engineered primary adult sheep muscle cells genetically engineered to express either rhVEGF or rhIGF-1 secreted the bioactive proteins locally in the sheep heart for at least 30 days.